Browse Data and Analysis

In September 2024, a National Assembly member submitted a draft revision of the Act on Transboundary Movements of Living Modified Organisms, commonly referred to as the LMO Act.

Sri Lanka’s agricultural biotechnology policies remain unchanged. Over the past year, there has been no progress in the approval of its draft Biosafety Act, which establishes a system to protect biodiversity, the environment and human, plant and animal health while minimizing the risks of biotechnology.

Korea has not finalized the May 2021 revisions of its Living Modified Organism (LMO) Act, which defines Korea’s regulatory policies for products developed through innovative technologies including genome editing.

Sri Lanka does not produce genetically engineered (GE) crops or animals. There is some GE research at the laboratory level, but there is no commercialization. The lack of a legal framework and biosafety procedures are a major setback; the country...

The Democratic Socialist Republic of Sri Lanka’s (Sri Lanka) Ministry of Health recently amended the Food (Control of Import, Labeling, and Sale of Genetically Modified Foods) Regulations (2006).

Sri Lanka does not produce genetically engineered (GE) crops or animals. There is some GE research at the laboratory level, but there is no commercialization. The lack of a legal framework and biosafety procedures are a major setback; the country is in the process of finalizing regulatory biotechnology policies.

Korea is in the process of drafting a proposal to revise its existing Living Modified Organism (LMO) Act to cover products of innovative biotechnologies, including genome edited products.

The Democratic Socialist Republic of Sri Lanka (Sri Lanka) does not produce genetically engineered (GE) crops or animals.

In April 2019, the Rural Development Administration (RDA) announced the creation of its Center to Commercialize New Breeding Technologies.

Sri Lanka does not produce genetically engineered (GE) crops or animals.

This report provides minimal updates compared to the previous year’s report.

After 10 years under the Living Modified Organism (LMO) Act, Korea plans to improve and revise the LMO Act to address stakeholders’ concerns.